Literature DB >> 28123570

Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells.

Lei Cui1, Jian Song2, Liting Wu3, Luhui Cheng1, Aijun Chen1, Yanlin Wang3, Yingdi Huang3, Liming Huang3.   

Abstract

The epidermal growth factor receptor (EGF-R) signaling pathway is thought to have an important role in the development and progression of several carcinomas, as it is associated with cell proliferation, differentiation and migration. Activation of EGF-R signaling regulates epithelial-mesenchymal transition (EMT)-associated invasion and migration in normal and malignant epithelial cells. However, the specific mechanisms have not yet been fully elucidated. The present study utilized wound healing assays, western blotting, flow cytometry and MTT assays to demonstrate that Annexin A2 (ANXA2) is a key regulatory factor in EGF-induced EMT in CaSki cervical cancer cells. Moreover, the increased expression levels of ANXA2 promoted cell viability and migration in human CaSki cells. It was also found that silencing ANXA2 partially reverses EGF-induced EMT and inhibits cell viability and migration in CaSki cells. These findings suggest that ANXA2 is a key regulator of EGF-induced EMT in CaSki cervical cancer cells.

Entities:  

Keywords:  Annexin A2; cell proliferation; epidermal growth factor receptor signaling; epithelial-mesenchymal transition

Year:  2016        PMID: 28123570      PMCID: PMC5244908          DOI: 10.3892/ol.2016.5406

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

Review 1.  Annexins: from structure to function.

Authors:  Volker Gerke; Stephen E Moss
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

2.  Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.

Authors:  Firdous Ahmad Bhat; G Sharmila; S Balakrishnan; R Arunkumar; P Elumalai; S Suganya; P Raja Singh; N Srinivasan; J Arunakaran
Journal:  J Nutr Biochem       Date:  2014-08-01       Impact factor: 6.048

Review 3.  The annexin A2 system and vascular homeostasis.

Authors:  Elle C Flood; Katherine A Hajjar
Journal:  Vascul Pharmacol       Date:  2011-03-29       Impact factor: 5.773

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

6.  Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.

Authors:  S P Mathur; R S Mathur; R C Young
Journal:  Am J Reprod Immunol       Date:  2000-10       Impact factor: 3.886

7.  Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.

Authors:  Meena Sharma; Robert T Ownbey; Mahesh C Sharma
Journal:  Exp Mol Pathol       Date:  2010-01-15       Impact factor: 3.362

Review 8.  Annexins--modulators of EGF receptor signalling and trafficking.

Authors:  Thomas Grewal; Carlos Enrich
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

9.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

10.  The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.

Authors:  Kota Yoshida; Saori Yoshida; Nan Choisunirachon; Tomochika Saito; Kaori Matsumoto; Kohei Saeki; Manabu Mochizuki; Ryohei Nishimura; Nobuo Sasaki; Takayuki Nakagawa
Journal:  J Vet Med Sci       Date:  2014-06-16       Impact factor: 1.267

View more
  9 in total

1.  Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial-mesenchymal transition.

Authors:  Dan Du; Yoko Katsuno; Dominique Meyer; Erine H Budi; Si-Han Chen; Hartmut Koeppen; Hongjun Wang; Rosemary J Akhurst; Rik Derynck
Journal:  EMBO Rep       Date:  2017-12-12       Impact factor: 8.807

2.  Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Xue Bai; Yun-Yun Li; Hong-Yan Zhang; Feng Wang; Hong-Liu He; Jin-Chao Yao; Ling Liu; Shan-Shan Li
Journal:  Onco Targets Ther       Date:  2017-06-02       Impact factor: 4.147

Review 3.  Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.

Authors:  Chang-Yu Chen; Yung-Song Lin; Chien-Ho Chen; Yin-Ju Chen
Journal:  J Biomed Sci       Date:  2018-03-29       Impact factor: 8.410

4.  Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ß induced epithelial mesenchymal transition via Src/ANXA2/STAT3.

Authors:  Murilo R Rocha; Pedro Barcellos-de-Souza; Annie Cristhine M Sousa-Squiavinato; Priscila V Fernandes; Ivanir M de Oliveira; Mariana Boroni; Jose A Morgado-Diaz
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

5.  Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers.

Authors:  Amira F Mahdi; Beatrice Malacrida; Joanne Nolan; Mary E McCumiskey; Anne B Merrigan; Ashish Lal; Shona Tormey; Aoife J Lowery; Kieran McGourty; Patrick A Kiely
Journal:  Cells       Date:  2020-06-30       Impact factor: 6.600

Review 6.  Annexin A2 and Kidney Diseases.

Authors:  Ling Lin; Kebin Hu
Journal:  Front Cell Dev Biol       Date:  2022-09-02

7.  Molecular analysis of Annexin expression in cancer.

Authors:  Tobias Hein; Peter H Krammer; Heiko Weyd
Journal:  BMC Cancer       Date:  2022-09-19       Impact factor: 4.638

8.  Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion.

Authors:  Joshua S Brzozowski; Danielle R Bond; Helen Jankowski; Belinda J Goldie; Rachel Burchell; Crystal Naudin; Nathan D Smith; Christopher J Scarlett; Martin R Larsen; Matthew D Dun; Kathryn A Skelding; Judith Weidenhofer
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism.

Authors:  Tong Wang; Zhiyong Wang; Ruifang Niu; Liang Wang
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.